D. E. Shaw & Co., Inc. - PHOENIX BIOTECH ACQUISITION ownership

Back to all holdings Add to watchlist

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 11 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$7,552,000
+2.4%
747,712
+1.7%
0.01%0.0%
Q2 2022$7,374,000
+20.9%
735,211
+20.6%
0.01%
+50.0%
Q1 2022$6,098,000
+29.3%
609,788
+28.1%
0.01%
+50.0%
Q4 2021$4,717,000–475,984–0.00%–
 Download
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2023
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders